Govt will celebrate Narayana Guru Jayanti, Siddaramaiah assures Billavas

Mangaluru, Jan 15: Thousands of people on Wednesday boarded boats from Ullal's Kotepura to join a massive protest against the amended Citizenship Act and National Register of Citizens (NRC) in Adyar here.

People travelling through boats and steamers decorated with national flags, raised slogans during their journey through the Netravathi River.

The innovative mode of transportation was used by the protestors to reach the venue, as it not only saved time but was also more convenient for the fishermen, as large number of people from this community joined the protest.

The protestors docked their boats at the shore, which was barely 500 metres from the site of protest, being held at Shah Ground in Adyar.

The distance between Kotepura to the Shah Ground is approximately 15 kilometres but protesters would have to walk more five kilometres to reach the venue because of heavy traffic.

Due to protest, the national highway was also blocked and resulted in huge traffic snarls on routes leading to agitation site. 

Bengaluru, Apr 19: The Karnataka government on Saturday ordered 2 lakh Personal Protective Equipment (PPE) kits from DHB Global and 1 lakh from other major pharmaceuticals, for the healthcare warriors treating coronavirus patients.

According to the State Health Department, these PPEs have 10 components as per global standards like a face mask to prevent healthcare professional from any liquid sprays, goggles for additional safety, N95 masks for protection of nasal and mouth areas, surgical masks, nitrile gloves, coverall suit, shoe cover, waste disposable bag, plastic apron, and protective gear.

Each of the products should have the relevant certificate from the Food and Drug Administration (USFDA) or equivalent certification.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.